EN
抗体药类似物
Research Grade Divozilimab
All
  • CatalogTD-HY257186
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsBCD-132,CAS:2254061-60-2
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Divozilimab


Catalog No. TD-HY257186
Species reactivity Human
Applications Research Grade Biosimilar
Host species Humanized
Isotype IgG1-Kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target B-lymphocyte surface antigen B1, Membrane-spanning 4-domains subfamily A member 1, MS4A1, Leukocyte surface antigen Leu-16, B-lymphocyte antigen CD20, Bp35, CD20
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession P11836
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names BCD-132,CAS:2254061-60-2
Background Divozilimab (BCD-132) is a humanised monoclonal antibody against CD20 (CD20). Divozilimab can be used for multiple sclerosis research.
Note For research use only. Not for use in clinical or therapeutic applications